CA Patent

CA2377746A1 — N-pyrazole a2a receptor agonists

Assigned to Gilead Sciences Inc · Expires 2000-12-28 · 25y expired

What this patent protects

2-adenosine N-pyrazole compounds having the following formula: (see formula I) and methods for using the compounds as A2A receptor agonists to stimulate mammalian coronary vasodilation for therapeutic purposes and for purposes of imaging the heart.

USPTO Abstract

2-adenosine N-pyrazole compounds having the following formula: (see formula I) and methods for using the compounds as A2A receptor agonists to stimulate mammalian coronary vasodilation for therapeutic purposes and for purposes of imaging the heart.

Drugs covered by this patent

Patent Metadata

Patent number
CA2377746A1
Jurisdiction
CA
Classification
—
Expires
2000-12-28
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.